Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

EstroG-100 & Black Cohosh To Be Tested Side-by-Side for Treating Menopause Symptoms
  • USA - English


News provided by

EstroG-100 c/o Helios CORP

Nov 25, 2014, 11:55 ET

Share this article

Share toX

Share this article

Share toX

Estro-G
Estro-G

Santa Fe, NM (PRWEB) November 25, 2014 -- Helios CORP, the maker of EstroG-100, has announced that they will be testing EstroG-100 in a side-by-side comparison with Black Cohosh. EstroG-100 has performed exceptionally in three clinical studies as a natural menopause ingredient. Among the results, studies showed that EstroG-100 works 6 times faster than Black Cohosh and has no estrogenic effect nor does it affect weight, body mass index, or liver enzymes. (1)

Studies showed that EstroG-100 works 6 times faster than Black Cohosh and has no estrogenic effect nor does it affect weight, body mass index, or liver enzymes.

Post this

“Many women are still taking Black Cohosh as a daily treatment for menopause symptoms; however, a variety of published studies show Black Cohosh is linked to liver toxicity, among other health risks,” (2) said Michael Jeffers, the president of Helios CORP. “EstroG-100 is new to the U.S. market, so we’re still educating consumers that there’s actually an effective and safe botanical treatment for menopause symptoms. We feel the best way to demonstrate that there is a better and safer choice than Black Cohosh is to launch a side-by-side study with EstroG-100.”

The 45 million women in menopause in 2013 combined with the projected 5,000 women slipping into menopause per day in the USA will take something for menopause daily for 5-7 years and as long as 15 years. (3) It is critical that women have a safe and effective treatment for menopause symptoms.

A report by the North American Menopause Society from October 2012 suggests that Black Cohosh should not be used frequently due to potential liver toxicity issues (4), and in 2013 the American Botanical Council published a paper in which Black Cohosh was shown to be one the most adulterated botanical extracts sold in the USA. (5)

EstroG-100 has been shown to be one of the safest and most effective menopause symptom ingredients on the market, having achieved an “NDI” rating by the FDA, the highest classification in the dietary supplement industry. The ingredient has shown proven success treating hot flashes, vaginal dryness, sleeplessness, fatigue, dizziness, nervousness, and menopause related blues. (6)

Most botanical menopause remedies take 6-8 weeks to work and may affect just one of the many symptoms associated with menopause. After three placebo controlled, double blind and randomized human clinical studies, EstroG-100 has been proven to work with unheard of speed—in as little as a week—and improve multiple symptoms for menopausal women.

For additional information about EstroG-100, please contact Michael Jeffers at info(at)estroG100(dot)com, or visit us online for more information at http://www.estroG100.com.

Resources:
Helios CORP conducted three human clinical studies. Two of the three are currently published.

(1). Phase 2: "The Effect of Herbal Extract (EstroG-100) on Pre-, Peri- and Post-Menopausal Women," Phytotherapy Research. 26: 510-516 (2012); Published online September 2, 2011 in Wiley Online Library. website: estrog100.com/media/files/04-EstroG-100-Phase-II_US-ClinicalStudy.pdf

(2). Mahady G, Low Dog T, Barrett M, Chavez M, Gardiner P, Ko R, et al. “United States Pharmacopeia review of the black cohosh case reports of hepatotoxicity,” Menopause: The Journal of the North American Menopause Society. 2008;15(4 Pt 1):628–638. website: drlowdog.com/Assets/pdf_files/BlackCohoshReview_USP.pdf

(3). North American Menopause Society. Overview of menopause and aging.October 15, 2012, website: menopause.org/docs/2012/cg_a.pdf?sfvrsn=2

(4). Gass MD, Margery. “Supplement safety: black cohosh & menopausal symptoms,” The North American Menopause Society. Oct 31 2012. website: menopause.org/for-women/menopause-take-time-to-think-about-it/consumers/2012/10/31/supplement-safety-black-cohosh-menopausal-symptoms

(5). Foster, Steven. “Exploring the Peripatetic Maze of Black Cohosh Adulteration: A Review of the Nomenclature, Distribution, Chemistry, Market Status, Analytical Methods, and Safety,” American Botanical Council. Issue 98, 32-51. Website: cms.herbalgram.org/herbalgram/issue98/hg98feat-blackcohosh.html?ts=1416884557&signature=92db80f3f0f61d62f61899e7cf92c87d&ts=1416928696&signature=38ceace21274fe419e907e9af7582d90

(6). Phase 1: "Evaluation of Effectiveness and Safety of Natural Plants Extract (Estromon®) on Perimenopausal Women for 1 Year," Journal of Korea Society of Menopause, Vol 11, No. 1, March 2005. Website: estrog100.com/media/files/05-EstroG-100-KoreaHumanClinicalStudy.pdf

Michael Jeffers, EstroG-100 c/o Helios CORP, http://www.estrog100.com, +1 505-982-8836, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.